Key Takeaways
- Mixed quarter shaped by deliberate portfolio choices: Crop Protection volumes fell but EBITDA rose as management swapped low-value tonnage for high-value formulations, while TiO2 losses deepened on a raw material cost spike that made every extra ton sold more painful.
- TiO2 is the open wound: Price realization stayed weak even with anti-dumping duty in place, and a sharp rise in key input costs forced a conservative posture: produce less to lose less. Management hopes for raw material softening and a loss reduction in Q3.
- Crop Nutrition is the bright spot: Revenue jumped on field trials, demonstrations and international trial orders; management called it not a one-off and set a three-digit crore revenue target for FY27.
- Disclosure discipline is tight: Management declined to quantify new-product margins, the revenue split from recently launched products, or any concrete TiO2 turnaround timeline, citing confidentiality and macro volatility.
- What to watch next quarter: Whether TiO2 raw material prices actually soften, whether the DGTR rework on anti-dumping duty concludes favorably, and whether Crop Nutrition sustains its revenue momentum.
TiO2: Losses, Pricing & the Anti-Dumping Overhang
- Price realization still under pressure: Chinese producers reduced prices further and dumped material into the market after the last call, and an extended rainy season stretched inventory liquidation across paint, ceramic and other end-use industries.
- Raw material cost spike changed the calculus: Key input prices shot up drastically, so the more the company produced and sold, the higher the loss. That forced a deliberate pullback in volumes, a dynamic management called not normal.
- Anti-dumping duty in limbo: The Indian Paint Association challenged the duty in Kolkata High Court and won a favorable ruling, but the duty was not removed. The court sent the matter back to DGTR to correct procedural lapses; customs continues to collect the duty pending a final notification, expected in 2–3 months.
- No backward or forward integration planned: Raw materials are too basic for backward integration, and forward integration into paints, ceramics or textiles is not under consideration. Management said it is working on a few other options but acknowledged no significant improvement in those strategies yet.
- Market opportunity narrative intact: Indian TiO2 demand sits at 4,50,000–5,00,000 tons and is expected to grow significantly, driven by the consumption pattern of a 140-crore population.
Patel: "The more we make, more we sell, the loss is even higher, which was not expected. This is not the normal scenario, what we have been seeing and that is the reason we have become a little more conservative."
Crop Protection: Volume Down, Margins Up by Design
- Deliberate portfolio rebalancing: Management evaluated product-wise profitability and market conditions, then reduced low-value, high-volume products and prioritized high-value, low-volume ones. The result: lower reported volume but higher segment EBITDA.
- Formulation capability as a moat: A fragmented product portfolio built over five years, combined with formulation expertise, enabled market share gains and better price realization even as the broader agrochemical industry faced headwinds. Global channel inventory has now cleared, and underlying demand is good, though customers remain cautious on tariff uncertainty.
- New-product pipeline extends to 2029: The company has lined up new product ranges, registrations and data generation work through the end of the decade. Product selection favors molecules with market growth potential, few competing players, and chemistry where backward integration is feasible.
- Margin disclosure declined: When asked for the EBITDA margin differential between new-generation products and the legacy portfolio, management called it confidential and declined to share specifics.
Crop Nutrition: Early Traction, Bullish Targets
- Revenue jump backed by field work: The increase was driven by field activity, demonstrations and registrations yielding positive responses, plus trial orders from international markets. Management explicitly stated this is not a one-off.
- Three-digit revenue target: The company aims to take Crop Nutrition revenue past ₹100 crores in FY27, calling the segment a significant growth driver over the next two years. More product introductions are planned within this financial year.
CPC Blue/Green & Other Segments
- CPC Blue/Green hit by tariffs: Over 75% of revenue comes from exports to the US and Europe. US tariff issues and European market softness caused a 15% volume reduction. Prices are at bottom levels but not declining further. Management sees this as a relatively stable business with no significant growth potential and wants to run it at an optimum level. A US-India trade deal could help demand.
- Crop Protection growth ambition: Management expects double-digit year-on-year growth for the next 4–5 years, largely driven by new products.
Working Capital & Balance Sheet
- Receivables stretched on aggressive crop protection business: The receivable period increased to 126 days from roughly 97 days, driven by higher-credit-oriented crop protection sales. Inventory days improved by about 18 days and payable days increased by roughly 10, keeping net working capital days in the same range.
TiO2 Turnaround: Timeline, Partnerships & the Exit Question
- Loss reduction hoped for in Q3: Management expressed hope for a reduction in TiO2 losses in the third quarter, but declined to commit to a breakeven or profitability timeline, citing global macro volatility.
- Technical partnerships on hold: The company has held discussions with a few potential partners, but interest will only materialize once market conditions improve. Management framed this as a timing issue: good times will bring opportunities, tough times require holding tight.
- No shutdown or divestment deadline: When asked directly whether there is a deadline to shut down or divest the TiO2 business if it cannot be turned around, management declined to give any timeline or commitment, saying it will take the right call based on market conditions and does not want to offer wrong assumptions.
Patel: "I don't want to give you the wrong assumption or wrong judgment when we will be able to turn it around. We have been working on it, but somehow the time is not correct and that is creating the problem for us."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| TiO2 raw material prices | Raw material prices should soften from current unsustainable levels | Within next 2 quarters |
| TiO2 loss reduction | Hope for reduction in loss | Q3 FY26 |
| DGTR final notification on ADD | Lapses corrected, final judgment issued | Next 2–3 months |
| Crop Nutrition revenue target | Revenue to reach three digits (₹100+ crores) | FY27 |
| Crop Protection growth | Double-digit YoY growth every year | Next 4–5 years |
| New Crop Nutrition products | Few more product introductions | This financial year |
| Maiden sustainability report | Publication | Next month |
| Price realization improvement | Little improvement expected as demand continues | Next year (FY27) |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Standalone revenue | ₹558 cr, up 5% YoY |
| Standalone EBITDA | ₹70 cr, up 71% YoY |
| Standalone PAT | ₹43 cr, vs ₹9 cr in Q2 FY25 |
| Consolidated revenue | ₹577 cr, up 6% YoY |
| Consolidated EBITDA | ₹52 cr, up 70% YoY |
| Consolidated PAT | ₹12 cr, vs loss of ₹9 cr in Q2 FY25 |
| H1 FY26 standalone revenue | ₹1,150 cr, up 22% YoY |
| H1 FY26 standalone EBITDA | ₹151 cr, up 173% YoY |
| H1 FY26 standalone PAT | ₹83 cr, vs ₹2 cr in H1 FY25 |
| Crop Protection segment revenue | ₹443 cr, up 11% YoY |
| Crop Protection segment EBITDA margin | ~17% |
| Crop Protection capacity utilization | ~72%, production ~10,136 MT |
| Pigment segment revenue | ₹115 cr |
| Pigment segment EBITDA margin | 3.5% |
| Pigment segment capacity utilization | ~45%, production 3,759 MT |
| Crop Nutrition revenue | ₹23 cr, up from ₹14 cr QoQ |
| Crop Nutrition FY27 revenue target | ₹100+ cr (three-digit target) |
| TiO2 segment quarterly EBITDA loss | ~₹25 cr (per an analyst's math) |
| CPC Blue/Green volume decline | ~15% |
| CPC Blue/Green price range | ~₹350–400 per kg |
| Standalone total debt | ₹597 cr, short-term ₹454 cr, long-term ₹143 cr |
| Consolidated total debt | ₹836 cr, short-term ₹479 cr, long-term ₹357 cr |
| Debt repayment in H1 FY26 | ~₹90 cr |
| Trade receivables days | 126 days, up from 97 days |
| Inventory days | Reduced by ~18 days |
| Payable days | Increased by ~10 days |
| Crop Protection export share | >80% of segment revenue |
| Crop Protection export mix | ~two-third technical, ~one-third formulation |
| Product registrations | ~780–790 as of March 2025 |
| Crop Protection growth outlook | Double-digit growth expected annually for next 4–5 years |